Inositol Aids in nutrient transport and electrolyte equilibrium
However, every treatment plan is personalized, so we can discuss your specific goals to determine the best strategy for you
Quick Takeaways Retatrutide is a triple-receptor agonist (GLP-1, GIP, glucagon) delivering superior monotherapy weight loss at 2428.7% over 4868 weeks Cagrilintide targets amylin receptors for satiety and gastric emptying, achieving 10.8% weight loss in 26 weeks as a monotherapy Retatrutide provides broader metabolic benefits, including dramatic improvements in HbA1c, blood pressure, waist circumference, insulin sensitivity, and liver fat normalization No head-to-head trials exist yet, but the mechanistic and clinical data strongly favor Retatrutide for total body recomposition Retatrutide vs Cagrilintide: Side-by-Side Comparison What Makes Retatrutide Different Retatrutide isnt just another GLP-1 receptor agonist
Click below to view purity certificates for every lot of this compound
Please verify you are ordering the correct item before checking out
What Category 1 Reclassification Does and Does Not Mean The 2026 update is easy to misunderstand because GHK-Cus status is not the same for every form